☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
zura bio
Zura Bio Reports $80M Financing and Licensing of ZB-106 from Eli Lilly for Autoimmune Diseases
April 28, 2023
Zura Bio to Go Public via JATT SPAC Merger for ~$215M
June 20, 2022
Load more...
Back to Home
Modal title
×
Modal body text goes here.
